Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.
Head of global nonprofit PATH explores how “social innovation” such as the Novartis Access program is helping expand access to healthcare in some of the world’s poorest countries.
In an editorial for Project Syndicate, Nick White, Professor of Tropical Medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, and Thierry Diagana, Head of the Novartis Institute for Tropical Disease, discuss how as the dream of eliminating malaria seems closer to becoming reality, growing drug resistance is threatening these remarkable gains.
In an editorial for Business Fights Poverty, David Reddy, CEO, Medicines for Malaria Venture and Jürgen Brokatzky-Geiger, Global Head of Corporate Responsibility, Novartis highlight the challenges and opportunities in the fight to eliminate malaria.
Researchers focus on reversing the scarring that’s common to liver diseases.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.